SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-12-232615
Filing Date
2012-05-15
Accepted
2012-05-15 06:16:47
Documents
2
Effectiveness Date
2012-05-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d353148ddefa14a.htm DEFA14A 24685
2 GRAPHIC g353148g69e37.jpg GRAPHIC 4265
  Complete submission text file 0001193125-12-232615.txt   31732
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19700 | Film No.: 12840900
SIC: 2834 Pharmaceutical Preparations